Uniphar, a global leader in pharmaceutical and medtech solutions has announced the launch of its 10th cell and gene therapy (CGT) project. The milestone reinforces Uniphar’s commitment to ...

EASYGEN is led by Fresenius and academically co-led by Fraunhofer Institute, IZI, Leipzig - one of Europe's foremost ...

Over the last 15 years, I have witnessed how cell and gene therapy (CGT) has evolved in many ways, spanning from research and development to manufacturing. Breakthroughs such as CAR-T and gene ...

The ability to correct disease-causing genetic mistakes using genome editors holds great promise in medicine, but it is not without risk. When this type of “genetic surgery” is performed on DNA, for ...

But there’s another field of human medicines managed under Marks’ previous leadership that could face significant disruptions—cell and gene therapies. To many in this realm of the biopharma ...

Bharat Biotech is pumping $75 million into a new cell and therapy manufacturing facility at the Indian drugmaker’s facility located in what is known as Genome Vally in Hyderabad.

Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing. | The California biotech will use the cash infusion to support its ...

Cell- and gene-therapy-focused ElevateBio has let go of 17% of staffers as part of the company’s second layoff round since raising $401 million nearly two years ago.

By using gene therapy to modify their HSCs — which give rise to all other blood cells — we can correct how their red blood cells are made. HSC gene therapy can be used for conditions caused by defects ...

Nicole Verdun's ouster followed a disagreement over review of cell therapy for Duchenne muscular dystrophy, long-simmering tensions over management style.

Because gene therapy can accurately identify and target cancerous cells to stop additional harm, it is an essential part of cancer treatment.